Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Share this video  

ESMO 2021 | The potential of ctDNA in oncology

Javier Garcia-Corbacho, MD, Hospital Clinic Barcelona, Barcelona, Spain, outlines the potential of circulating tumor DNA (ctDNA) for diagnosis and for monitoring response to treatment and disease evolution and predicts that it will soon be used in standard clinical practice. This interview took place at the European Society for Medical Oncology (ESMO) 2021 congress.

Disclosures

Dr Garcia-Corbacho declares participation in multiple clinical trials and meetings as speaker (advisory role) and financial sponsor support for meeting attendance.

Choose your cookie settings

VJOncology uses necessary cookies to make the site work. With your permission we'd also like to use analytics, preference and marketing cookies to understand how the site is used and improve it.

Choose an option to continue. You can change it at any time on our Cookie Policy page, linked at the bottom of every page.